[Ghrelin and bone metabolism].
Komatsu
Yasato
Y
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
Nakao
Kazuwa
K
D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000378:metabolism*; D005743:Gastrectomy / Q000009:adverse effects; D005753:Gastric Mucosa / Q000378:metabolism; D054439:Ghrelin; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D015282:Octreotide / Q000494:pharmacology / Q000627:therapeutic use; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D036361:Peptide Hormones / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology*; D013141:Spiro Compounds / Q000494:pharmacology / Q000627:therapeutic use
D015415:Biomarkers; D054439:Ghrelin; D007211:Indoles; D036361:Peptide Hormones; D013141:Spiro Compounds; D015675:Osteocalcin; D007334:Insulin-Like Growth Factor I; C094817:ibutamoren mesylate; D015282:Octreotide